|
|
|
Pharmaceutical Manufacturing and Packing Sourcer |
|
|
|
|
This special edition of PMPS features a Parenteral Technology Supplement, assessing the current and future shape of this expanding market. Click here to view the digital edition, or scroll down to read individual articles below.
Click here to view the regular edition of PMPS August, or browse individual articles below.
|
 |
| |
|
|
|
|
Industry Insight
PMPS Industry Advisor, Robert Harris, outlines the main subjects addressed in this edition and introduces our special Parenteral Technology Supplement.
|
|
|
|
|
Modal Shift
Turbulent Times
How legitimate are claims that sea is becoming preferable to air transport when distributing pharma freight? Taking a look at the bigger picture, Alan Kennedy at PartnerSave finds that technology will ultimately have the final say.
|
|
|
Temperature-Controlled Systems
Follow That Car
As the potential impact of temperature-controlled packaging on the environment becomes ever-clearer, David Johnson at Intelsius urges manufacturers to alter their outlook on containment solutions, including full lifecycle and means of disposal.
|
|
|
|
|
Intelligent Drug Delivery
Wide Eyed
Writing for Nemera, Katriona Scoffin reveals how innovative new designs have enabled the production of multi-dose preservative-free eye drop bottles, providing an easy way to deliver safe and cost-effective treatments.
|
|
|
|
RFID Smart Cabinets
A Clearer Tomorrow
Shruthi Parakkal at Frost & Sullivan predicts a promising future for radio-frequency identification in tackling counterfeit drugs. It is only a matter of time before companies realise the myriad benefi ts to be gained from its adoption.
|
|
|
|
Good Distribution Practice
Chain Compliance
Reflecting on how evolving EU Good Distribution Practice requirements have compelled service providers to consolidate their quality systems with those of pharmaceutical companies, World Courier’s Stanley Soh believes this will be for the greater good of the supply chain as a whole.
|
|
|
|
Medical Device Supply Chain
Change For The Better
Susanne Amholt at DHL outlines three key distribution trends that are currently weighing heavy on medical device manufacturers. It is not all doom and gloom, however; with a more versatile approach, these outward challenges can be surmounted.
|
|
|
Supplier Relationships
Setting Standards
Maria D’Orazio at Novartis Vaccines investigates the impact of the revised EU Good Distribution Practice Guidelines on outsourced activities and considers the questions pharma businesses should ask when selecting a logistics partner.
|
|
|
|
Orbital Shrink Wrapping
Outside the Box
The latest multipack shrink wrapping technology improves product integrity and production efficiency, not to mention its packaging flexibility over corrugated materials. Tom Dickman at Texwrap Packaging Systems reports.
|
|
|
Label Lifecycle Management
Business Gain Without The Pain
Label lifecycle management is often believed to be difficult to implement, and can therefore fall off the radar. Dispelling this myth, Dave Taylor at PRISYM ID contends that the operational gains achieved by using this approach should come quickly and cheaply.
|
|
|
|
Pharmerging Markets
Eastern Promise
Emerging markets are increasingly moving towards greater investment in R&D and improved manufacturing standards – particularly in Asian countries. Jonathan Wilkins at European Automation welcomes this evolution, which he believes is critical in order to capitalise on the best business opportunities.
|
|
|
|
|
Health and Safety
Hidden Dangers
Despite recent regulatory updates limiting exposure to hazardous materials, more needs to be done to prevent long-term health issues among employees in pharmaceutical manufacturing. Casella’s Andrea Bowen calls for increased investment in this area.
|
|
|
|
Foreword
Welcome to the Parenterals Universe
Introducing this special supplement, Dr Friedrich Haefele, Chair of The
Universe of Pre-filled Syringes and Injection Devices, looks ahead to
November’s conference, which will assess the current and future shape of
the parenterals market |
|
|
Patient Adherence
Tapping into Apps
App initiatives are now being rolled out across the pharma industry, offering valuable patient data and improving medication compliance. Chris Evans from West Pharmaceutical Services explores how this technology is being utilised with self-injection systems for chronic disease patients.
|
|
|
Aseptic Processing
BFS Explained
With traditional glass vial filling prone to potential contamination, alternative blow-fill-seal technology looks set to expand into the injectables market. Bill Hartzel at Catalent Pharma Solutions assesses its ability to design out risks and looks at research backing its safety and reliability.
|
|
|
Needle Design
Pain and Porcupines
The daily fear and pain some patients experience with needles has prompted new designs with varying tip shapes and diameters. But, as Philip Canner at Team Consulting explains, further efforts are needed to address penetration and insertion concerns – and unique microscopic barbs could provide some answers.
|
|
|
Auto-Injectors
Forward Thinking
Next-generation auto-injectors will need to overcome some of the known problems with conventional spring-based systems and high-viscosity formulations, which can hinder fast injection times. Bespak Europe’s Steven R Kaufman considers biopharma’s product needs.
|
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Dempsey Demystifies Regulatory Cycle at DIA Europe
March 22, 2018 (Hartford, Conn.) – RWS Life Sciences Managing Director,
Sheena Dempsey, will present “Demystifying the Multilingual Complexities
in the Regulatory Cycle” at DIA Europe 2018, on April 17, at 3:30PM
(CET), in Basel, Switzerland.
More info >> |
|
 |
White Papers |
 |
|
The Impact of Components on Drug Quality and Risk Mitigation
West Pharmaceutical Services, Inc.
Expectations for quality by regulatory agencies are increasing at a very fast pace, especially for prefilled drug delivery formats, thanks to increased focus on reducing risk to patient safety. The trend has resulted in delays for new drug applications, more recalls of marketed products and even drug shortages if the container system and drug contents are suspect for quality issues. The pharmaceutical market is now requiring manufacturers of containers and components to meet new expectations with a quality culture and very high product reliability. The need to bridge the gap and provide superior quality products has been a driver for manufacturing technology investments, more robust control strategies and the introduction of next generation elastomer components.
More info >> |
|
 |
Industry Events |
 |
BioTrinity 2018
23-25 April 2018, Novotel London West in Hammersmith
BioTrinity
2018 is taking place from 23-25 April at the Novotel London West in
Hammersmith. Now in its 12th year, BioTrinity remains the leading life sciences biopartnering
and investment conference in Europe, and is a must attend event for R&D
companies, TTO’s and academia who are looking to meet, collaborate, partner and
seek funding from Big Pharma, Investors and Associated Industry companies.
More info >> |
|
|
